| Name | Title | Contact Details |
|---|---|---|
Monica Haines |
Director, Strategic Content Marketing | Profile |
Vik Anantha |
Chief Product and Marketing Officer | Profile |
Peter Weiss |
Director of Product Management | Profile |
Rebecca Jeglum |
Vice President of Human Resources | Profile |
Inka Wolfermann |
Vice President Human Relations | Profile |
Founded in 1991, AdCare Health Systems, Inc. (NYSE MKT: ADK) is a leading provider of senior living and health care facility management, dedicated to providing the highest quality of healthcare services to the elderly. AdCare operates 46 facilities in Alabama, Arkansas, Georgia, Ohio, Oklahoma, North Carolina, Missouri and South Carolina, with approximately 4,700 beds in service. The facilities comprise 43 skilled nursing centers, three assisted living residences and one senior independent living facility. AdCare owns 24 of the skilled nursing centers and two of the assisted living facilities, with the others operated under long-term lease, consolidated variable interest entity, or management contract.
Cato Research is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Make a difference—in your life and in the world—with a rewarding career at Gillette Children`s Specialty Healthcare. Gillette is a Twin Cities Top Workplace and a National Top Workplace. We offer competitive pay, a strong benefits package and flexible schedules. Plus we give employees something that sets us apart: a chance to take part in our mission. Come to work for Gillette, and you`ll improve the lives of countless children and adults who have disabilities or complex medical conditions. Each year, we see more patients and add more services. That growth enabled us to increase our workforce by more than 30 percent during the past five years. As we continue expanding, you`ll have many chances to learn new skills and advance your career. You`ll also collaborate with teams of caring professionals who are committed to making the world a better place.
Kymera is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s own natural protein degradation system. Kymera’s proprietary targeted protein degradation platform, called Pegasus, enables us to discover highly selective small molecule protein degraders with activity against disease-causing proteins throughout the body. We believe that our small molecule protein degraders have significant advantages over existing therapies and allow us to address a large portion of the human genome that was previously intractable with traditional modalities. Kymera focuses on biological pathways that have been clinically validated but where key biological nodes/proteins have not been drugged or have been inadequately drugged. To date, we have utilized our Pegasus platform to design novel protein degraders focused in the areas of immunology-inflammation and oncology, and continue to apply our platform’s capabilities to additional therapeutic areas.
EcoNugenics® was founded in 1995 by Dr. Isaac Eliaz, M.D., M.S., L.Ac. - a pioneer and expert in the field of integrative medicine, and a highly regarded clinical practitioner, formulator, researcher and author. Dr. Eliaz leads our research activities in natural, integrative approaches to cellular, immune, metabolic, digestive, and cardiovascular health, as well as detoxification.